WASHINGTON, United States (AFP) -by Douglas Gillison The embattled manufacturer of EpiPens said Thursday it would help extreme allergy sufferers meet the costs of the life-saving devices after a five-fold price hike sparked outrage. Mylan NV, which holds a near-monopoly on the manufacture of the epinephrine injectors, said it would expand existing programs to defray out-of-pocket costs but did not say it would lower prices. After a series of price hikes, a pack of two […]